DCL: Explanation for business result of parent company in QIV/2012
Cuu Long Pharmaceutical Joint Stock Corporation (PHARIMEXCO) explained the fluctuation in consolidated profit in Quarter IV/2012 compared to Quarter IV/2011 as follows:
- Profit after tax in Quarter III/2012: VND9,50,463,483 - Profit after tax in Quarter III/2011: -VND23,001,22,633 - Increased : VND32,561,686,116 (over 10%) Reason: Financial expenses in Quarter 4/2012 was VND14.416 billion, decreasing VND 8.273 billion compared to in Quarter 4, 2011 because interest expenses decreased. Selling expenses in Quarter 4/2012 decreased VND16.132 billion because the company changed selling policy.
- Profit after tax in Quarter III/2012: VND9,50,463,483
- Profit after tax in Quarter III/2011: -VND23,001,22,633
- Increased : VND32,561,686,116 (over 10%)
Reason:
Financial expenses in Quarter 4/2012 was VND14.416 billion, decreasing VND 8.273 billion compared to in Quarter 4, 2011 because interest expenses decreased.
Selling expenses in Quarter 4/2012 decreased VND16.132 billion because the company changed selling policy.
HOSE
> DMC: Personnel change and setting up Branch (04/03/2013)
> KSS: Explanation for business result in Q4.2012 (04/03/2013)
> PNJ: Resolution on organizing the AGM 2013 (04/03/2013)
> VietinbankSc: Information on Audited FS 2012 (04/03/2013)
> SHBS: Information on Audited FS 2012 & capital adequacy ratio (04/03/2013)
> NVS: Information on Audited FS 2012 & capital adequacy ratio (04/03/2013)
> SDT: Financial Statement FY 2012 (holding company) (04/03/2013)
> PRUBF1: Notice of Annual General Meeting of Shareholders 2012 (04/03/2013)
> BTT: The Record Date for Annual General Meeting 2013 (04/03/2013)
> DHG: The Record Date for Annual General Meeting 2012 (04/03/2013)